Key Opinion Leader & Stakeholder Management in Specialty & Orphan Therapeutics

Faced by a harsher economic and political landscape, it is increasingly evident that traditional pharmaceutical sales and commercial models are no longer as effective as they once were.

This has required the pharma industry to adapt and develop new customer engagement strategies in order to maintain revenue of existing medications and to allow the success of new drugs entering the market. As mass-market blockbusters are lost to generic competition, specialty, niche medications, prescribed by specialists are increasingly beginning to dominate product portfolios. Specialist prescribers have never more become such an important customer segment, who need a lot of information to prescribe these typically expensive and novel small and large molecule drugs. New ways to engage with specialty prescribers and stakeholders are clearly now required.

For more information and registration please visit the Conference Website